×

Incannex Healthcare Limited

Incannex Healthcare Limited (IHL.ASX) is an innovator and developer of medicinal cannabinoid pharmaceutical products with global export capability.

IHL is currently undertaking 4 significant clinical programs to develop 4 uniquely formulated products in its relentless pursuit of FDA registration and market exclusivity over the following indications:

  • Obstructive Sleep Apnoea (‘OSA’)
  • Traumatic Brain Injury (‘TBI’)/Concussion
  • Sepsis Associated Acute Respiratory Distress Syndrome (‘SAARDS’)
  • Temporomandibular Joint Disorder (‘TMJD’).

    IHL

Videos

Videos coming soon for Incannex Healthcare Limited.

News